Neuland Laboratories Limited (NSE:NEULANDLAB) — Stock Price

Rs22216.00 INR
▼ -2.80% today

Neuland Laboratories Limited (NSE:NEULANDLAB) is currently trading at Rs22216.00 INR, down 2.80% today. Over the past 52 weeks, shares have ranged between Rs11555.00 and Rs22855.00. This page tracks Neuland Laboratories Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Neuland Laboratories Limited.

Neuland Laboratories Limited (NEULANDLAB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Neuland Laboratories Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Neuland Laboratories Limited Income Statement — Revenue, Profit & Earnings by Year

Neuland Laboratories Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs20.23 Billion Rs14.34 Billion Rs15.16 Billion Rs11.61 Billion Rs9.23 Billion
Cost of Revenue Rs13.80 Billion Rs7.51 Billion Rs7.34 Billion Rs6.14 Billion Rs5.54 Billion
Gross Profit Rs6.43 Billion Rs6.84 Billion Rs7.82 Billion Rs5.47 Billion Rs3.70 Billion
Research & Development — Rs612.40 Million Rs349.92 Million Rs277.58 Million Rs3.64 Million
SG&A — Rs372.96 Million Rs309.17 Million Rs298.91 Million Rs156.93 Million
Total Operating Expenses Rs1.60 Billion Rs4.17 Billion Rs3.74 Billion Rs3.13 Billion Rs2.74 Billion
Operating Income Rs4.83 Billion Rs2.67 Billion Rs4.07 Billion Rs2.34 Billion Rs960.90 Million
EBITDA Rs5.74 Billion Rs4.18 Billion Rs4.72 Billion Rs2.79 Billion Rs1.41 Billion
EBIT Rs4.83 Billion Rs3.52 Billion Rs4.13 Billion Rs2.26 Billion Rs916.96 Million
Interest Expense Rs239.47 Million Rs82.97 Million Rs139.97 Million Rs130.67 Million Rs134.95 Million
Income Before Tax Rs4.89 Billion Rs3.46 Billion Rs4.01 Billion Rs2.16 Billion Rs821.62 Million
Income Tax Expense Rs1.25 Billion Rs862.21 Million Rs1.01 Billion Rs522.29 Million Rs183.41 Million
Net Income Rs3.64 Billion Rs2.60 Billion Rs3.00 Billion Rs1.64 Billion Rs638.22 Million

Neuland Laboratories Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Neuland Laboratories Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs29.30 Billion Rs21.80 Billion Rs18.33 Billion Rs15.80 Billion Rs13.83 Billion
Total Current Assets Rs14.83 Billion Rs11.39 Billion Rs9.21 Billion Rs7.61 Billion Rs5.81 Billion
Cash & Equivalents — Rs630.50 Million Rs770.60 Million Rs136.88 Million —
Short-term Investments Rs2.83 Billion Rs2.34 Billion Rs150.10 Million Rs135.72 Million Rs33.77 Million
Net Receivables Rs5.41 Billion Rs3.16 Billion Rs3.83 Billion Rs3.72 Billion Rs2.38 Billion
Inventory Rs5.10 Billion Rs3.86 Billion Rs3.50 Billion Rs2.79 Billion Rs2.65 Billion
Property, Plant & Equipment — Rs7.18 Billion Rs5.69 Billion Rs4.98 Billion Rs4.87 Billion
Goodwill Rs2.79 Billion Rs2.79 Billion Rs2.79 Billion Rs2.79 Billion Rs2.79 Billion
Total Liabilities Rs10.56 Billion Rs6.55 Billion Rs5.50 Billion Rs5.86 Billion Rs5.43 Billion
Total Current Liabilities Rs7.10 Billion Rs4.66 Billion Rs4.28 Billion Rs4.39 Billion Rs3.63 Billion
Long-term Debt Rs1.61 Billion Rs907.27 Million Rs449.21 Million Rs742.46 Million Rs1.04 Billion
Net Debt Rs-536.93 Million Rs252.07 Million Rs78.14 Million Rs830.34 Million Rs2.35 Billion
Total Stockholder Equity Rs18.74 Billion Rs15.25 Billion Rs12.83 Billion Rs9.94 Billion Rs8.41 Billion
Retained Earnings — Rs9.95 Billion Rs7.52 Billion Rs4.65 Billion Rs3.08 Billion

Neuland Laboratories Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Neuland Laboratories Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs3.38 Billion Rs3.17 Billion Rs2.56 Billion Rs2.39 Billion Rs585.81 Million
Capital Expenditures Rs3.97 Billion Rs2.06 Billion Rs1.44 Billion Rs661.27 Million Rs958.78 Million
Free Cash Flow Rs-588.87 Million Rs1.11 Billion Rs1.12 Billion Rs1.72 Billion Rs-372.97 Million
Investing Cash Flow Rs-4.32 Billion Rs-2.98 Billion Rs-1.50 Billion Rs-614.99 Million Rs-937.08 Million
Financing Cash Flow Rs380.18 Million Rs249.61 Million Rs-559.00 Million Rs-1.36 Billion Rs377.21 Million
Dividends Paid Rs-153.96 Million Rs-179.62 Million Rs128.30 Million Rs64.15 Million Rs38.49 Million
Stock-Based Compensation — — — — —
Depreciation Rs917.39 Million Rs655.47 Million Rs597.00 Million Rs527.76 Million Rs490.40 Million
Change in Cash Rs2.23 Billion Rs443.55 Million Rs712.63 Million Rs412.39 Million Rs26.56 Million

Neuland Laboratories Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Neuland Laboratories Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 13, 2026 — 78.16 —
Feb 09, 2026 31.62 56.52 -44.06%
Nov 07, 2025 75.49 54.92 +37.45%
Jul 31, 2025 10.83 51.53 -78.98%
May 15, 2025 21.67 44.26 -51.04%
Feb 10, 2025 44.61 48.15 -7.35%
Nov 06, 2024 25.60 50.15 -48.95%
Aug 01, 2024 64.16 50.63 +26.72%